These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 11144253)
1. Production of terbium-152 by heavy ion reactions and proton induced spallation. Allen BJ; Goozee G; Sarkar S; Beyer G; Morel C; Byrne AP Appl Radiat Isot; 2001 Jan; 54(1):53-8. PubMed ID: 11144253 [TBL] [Abstract][Full Text] [Related]
2. A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative. Müller C; Zhernosekov K; Köster U; Johnston K; Dorrer H; Hohn A; van der Walt NT; Türler A; Schibli R J Nucl Med; 2012 Dec; 53(12):1951-9. PubMed ID: 23139086 [TBL] [Abstract][Full Text] [Related]
3. Theranostic Terbium Radioisotopes: Challenges in Production for Clinical Application. Naskar N; Lahiri S Front Med (Lausanne); 2021; 8():675014. PubMed ID: 34136508 [TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with Baum RP; Singh A; Benešová M; Vermeulen C; Gnesin S; Köster U; Johnston K; Müller D; Senftleben S; Kulkarni HR; Türler A; Schibli R; Prior JO; van der Meulen NP; Müller C Dalton Trans; 2017 Oct; 46(42):14638-14646. PubMed ID: 28825750 [TBL] [Abstract][Full Text] [Related]
5. Cyclotron production and radiochemical purification of terbium-155 for SPECT imaging. Favaretto C; Talip Z; Borgna F; Grundler PV; Dellepiane G; Sommerhalder A; Zhang H; Schibli R; Braccini S; Müller C; van der Meulen NP EJNMMI Radiopharm Chem; 2021 Nov; 6(1):37. PubMed ID: 34778932 [TBL] [Abstract][Full Text] [Related]
6. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application. Müller C; Domnanich KA; Umbricht CA; van der Meulen NP Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792 [TBL] [Abstract][Full Text] [Related]
7. Terbium-149 production: a focus on yield and quality improvement towards preclinical application. Favaretto C; Grundler PV; Talip Z; Köster U; Johnston K; Busslinger SD; Sprung P; Hillhouse CC; Eichler R; Schibli R; Müller C; van der Meulen NP Sci Rep; 2024 Feb; 14(1):3284. PubMed ID: 38332245 [TBL] [Abstract][Full Text] [Related]
8. Cross section measurement of terbium radioisotopes for an optimized Dellepiane G; Casolaro P; Favaretto C; Grundler PV; Mateu I; Scampoli P; Talip Z; van der Meulen NP; Braccini S Appl Radiat Isot; 2022 Jun; 184():110175. PubMed ID: 35344829 [No Abstract] [Full Text] [Related]
9. Chemical Purification of Terbium-155 from Pseudo-Isobaric Impurities in a Mass Separated Source Produced at CERN. Webster B; Ivanov P; Russell B; Collins S; Stora T; Ramos JP; Köster U; Robinson AP; Read D Sci Rep; 2019 Jul; 9(1):10884. PubMed ID: 31350422 [TBL] [Abstract][Full Text] [Related]
10. Future prospects for SPECT imaging using the radiolanthanide terbium-155 - production and preclinical evaluation in tumor-bearing mice. Müller C; Fischer E; Behe M; Köster U; Dorrer H; Reber J; Haller S; Cohrs S; Blanc A; Grünberg J; Bunka M; Zhernosekov K; van der Meulen N; Johnston K; Türler A; Schibli R Nucl Med Biol; 2014 May; 41 Suppl():e58-65. PubMed ID: 24360901 [TBL] [Abstract][Full Text] [Related]
11. Co-production of Moiseeva AN; Makoveeva KA; Furkina EB; Artyushova EV; German MN; Khomenko IA; Konevega AL; Kormazeva ES; Novikov VI; Aksenov NV; Gustova NS; Aliev RA Nucl Med Biol; 2023; 126-127():108389. PubMed ID: 37783103 [TBL] [Abstract][Full Text] [Related]
12. Determination of the Terbium-152 half-life from mass-separated samples from CERN-ISOLDE and assessment of the radionuclide purity. Collins SM; Köster U; Robinson AP; Ivanov P; Cocolios TE; Russell B; Fenwick AJ; Bernerd C; Stegemann S; Johnston K; Gerami AM; Chrysalidis K; Mohamud H; Ramirez N; Bhaisare A; Mewburn-Crook J; Cullen DM; Pietras B; Pells S; Dockx K; Stucki N; Regan PH Appl Radiat Isot; 2023 Dec; 202():111044. PubMed ID: 37797447 [TBL] [Abstract][Full Text] [Related]
14. Preclinical in vivo application of (152)Tb-DOTANOC: a radiolanthanide for PET imaging. Müller C; Vermeulen C; Johnston K; Köster U; Schmid R; Türler A; van der Meulen NP EJNMMI Res; 2016 Dec; 6(1):35. PubMed ID: 27108447 [TBL] [Abstract][Full Text] [Related]
15. Terbium Medical Radioisotope Production: Laser Resonance Ionization Scheme Development. Gadelshin VM; Formento Cavaier R; Haddad F; Heinke R; Stora T; Studer D; Weber F; Wendt K Front Med (Lausanne); 2021; 8():727557. PubMed ID: 34712678 [TBL] [Abstract][Full Text] [Related]
16. Targeted alpha therapy: evidence for potential efficacy of alpha-immunoconjugates in the management of micrometastatic cancer. Allen BJ Australas Radiol; 1999 Nov; 43(4):480-6. PubMed ID: 10901964 [TBL] [Abstract][Full Text] [Related]
17. Tandem Van de Graaff accelerator production of positron labeled radiopharmaceuticals for routine clinical use. Jones SC; Robinson GD; McIntyre E Int J Appl Radiat Isot; 1984 Aug; 35(8):721-9. PubMed ID: 6332785 [TBL] [Abstract][Full Text] [Related]
18. A heavy-ion production channel of Wilkinson JT; Barrett KE; Ferran SJ; McGuinness SR; McIntosh LA; McCarthy M; Yennello SJ; Engle JW; Lapi SE; Peaslee GF Appl Radiat Isot; 2021 Dec; 178():109935. PubMed ID: 34555596 [TBL] [Abstract][Full Text] [Related]
19. Cyclotrons and radiopharmaceuticals in positron emission tomography. Council on Scientific Affairs. Report of the Positron Emission Tomography Panel. JAMA; 1988 Mar; 259(12):1854-60. PubMed ID: 3278157 [TBL] [Abstract][Full Text] [Related]
20. Production of Sc medical radioisotopes with proton and deuteron beams. Sitarz M; Szkliniarz K; Jastrzębski J; Choiński J; Guertin A; Haddad F; Jakubowski A; Kapinos K; Kisieliński M; Majkowska A; Nigron E; Rostampour M; Stolarz A; Trzcińska A; Walczak R; Wojtkowska J; Zipper W; Bilewicz A Appl Radiat Isot; 2018 Dec; 142():104-112. PubMed ID: 30273758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]